Collins B., Bom Kahama C., Raben C. European Testing Week: Adaptation of testing services during the COVID-19- pandemic. Oral presentation of abstract for “PLENARY SESSION 1: SPECIAL SESSION: Impact of COVID-19 on prevention and testing services for HIV, viral hepatitis, STIs and TB: Building back better”, at the HepHIV Conference, 6 May 2021.
Stengaard AR, Sullivan AK, Kowalska JK, Rokx C, Raben D, Simões D, The EuroTEST COVID-19 impact assessment consortium of partners. Impact of the COVID-19 pandemic on testing and linkage to care for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. HepHIV 2021 Conference, 6 May 2021.
Cosmaro L, Savarino D, Mommi M, Dominkovic Z, Simkunaite-Zazecke A, Stoniene L, Raahauge A, Kakalou C, Drosou V, Natsiavas P. RiskRadar: the 1st integrated ICT tool on combination prevention for hepatitis/HIV/TB/STI. HepHIV 2021 Conference, 6 May 2021.
Stengaard AR. Assessing the impact of COVID-19 on testing for HIV, viral hepatitis and STIs in the WHO European Region. Viral Hepatitis Prevention Board Technical Meeting, 25 March 2021.
Simões D. Key findings from the EuroTEST assessment of the impact of COVID-19 on testing in Europe. IUSTI Europe and BASHH United Kingdom monthly webinar, 31 March 2021.
Collins B., “Catch up on testing”, European Testing Week 22-29 November; testing for viral hepatitis, HIV and STIs. Presentation for “Special Session – Testing Week Campaigns: An effective tool for increasing HIV and integrated testing rates in key populations during and beyond Covid-19”, at the EACS Conference in London and online, 28 October 2021.
Collins B., Bom Kahama C.European Testing Week. Presentation at International and European Testing Week launch event in Lisbon and online, 22 November 2021.
Stoniene L, Subata E, Sirvinskiene A, Grice A, Jakobsen ML, Finne Jakobsen S, Raben D, Rae C, Sullivan AK. Expanding integrated HCV/HIV testing to alcohol dependent clients attending treatment centres for drug and alcohol dependency in Lithuania. HepHIV 2021 Conference, 5-7 May 2021.
Simões D. EuroTest update. Presentation for the ECDC/WHO Addressing TB, HIV and viral hepatitis during the COVID-19 pandemic: Programme Managers / National Focal Points and partners meeting, September 23-24, 2020.
Simões D. Impact assessment of COVID-19 pandemic on HIV/ hepatitis response and recommendation on maintenance of essential services. Presentation for the ECDC/WHO annual TB, HIV and viral hepatitis Programme Managers and partners meeting, 24 Sept 2020.
Stengaard A. Assessing the impact of COVID-19 on testing for multiple infectious diseases in the WHO European Region. Presentation for the EMCDDA Drug-related infectious diseases (DRID) network meeting, 22 October 2020.
Lundgren J. Impact of COVID-19 on HIV, Hepatitis and TB services: What are the consequences and what are the chances? Presented for the roundtable discussion at the EACS Standard of Care for Coinfections in Europe 4th meeting, 22 October 2020.
Raben D. Indicator Condition Guided Testing for HIV, viral hepatitis and STIs – increasing provider-initiated testing. Presentation for the WHO technical consultation on Optimizing HIV Testing Services Using HIV Risk Assessment Tools, 11-13 November 2020.
Simões D. EuroTEST update and results from the EuroTEST COVID-19 impact assessment on testing. Presentation for the WHO/ECDC World AIDS Day webinar on Measuring progress, looking forward: HIV in Europe and Central Asia, 30 November 2020.
Croxford S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobson SF, Amato-Gauci AJ, Desai S. Community-based HIV testing in Europe: a systematic review. Oral presentation at the sixth HepHIV conference; Bucharest; 2019 Jan 28-30.
Sullivan AK, Croxford S, Desai S, Combs L, Tavoschi L, Mason L, Delpech V, Hoekstra M, Jakobsen SF, Amato-Gauci AJ, Raben D. Evidence-based public health guidance for integrated HBV, HCV and HIV testing in Europe. Oral presentation at the sixth HepHIV conference; Bucharest; 2019 Jan 28-30.
Croxford S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobson SF, Amato-Gauci AJ, Desai S. HIV self-sampling and self-testing in Europe: a systematic review. Poster presentation at the sixth HepHIV conference; Bucharest; 2019 Jan 28-30.
Ben Collins on behalf of the European Testing Week Working Group. Preliminary results from the evaluation of the 2018 November ETW. Presentation at the European Testing Week Special Session at the sixth HepHIV conference; Bucharest; 2019 Jan 28-30.
Marinela Debu on behalf of the European Testing Week Working Group. Results from the May 2018 Spring European Testing Week pilot. Presentation at the European Testing Week Special Session at the sixth HepHIV conference; Bucharest; 2019 Jan 28-30.
Ben Collins on behalf of the European Testing Week Working Group. HIV, viral hepatitis and sexually transmitted infections: Maximising testing opportunities through integrating services. Presentation at the Wellbeing Economy – a Way to Sustainability in the HIV and AIDS Response; Helsinki; 4 October 2019.
Lauren Combs on behalf of the European Testing Week Working Group and EuroTEST Steering Committee. Seven years of European Testing Week: impact of a regional awareness campaign on increase in awareness and testing activities in Europe. Poster presentation at the 17th European AIDS Conference; Basel; 6-9 November 2019.
Dorthe Raben on behalf of INTEGRATE and EuroTEST. How can we improve monitoring of HIV and integrated testing in the EU/EEA?. Presentation at the European Centre for Disease Prevention and Control Dublin Declaration Advisory Group Meeting; Stockholm; 9-10 December 2019.
Daamen C, James C, Mukiwa T, Garner A, Harrison-Quintana J, Hodson M, Combs L, Noori T. Going new ways to end HIV: reaching men who have sex with men through a community, business, and public health partnership to increase HIV testing. Presented at: III International Conferences on Health Communication (HIV and Communication); 2018 21-22 November; Barcelona, Spain.
Daamen C, on behalf of the European Testing Week Working Group. European Testing Week: Are You In? Presented at: EU Think Tank on HIV, TB and Hepatitis; 2018 8 November; Brussels, Belgium
Grecu VI, on behalf of Integrate Joint Action. Joint Action on Integration of testing and linkage to care for HIV, viral hepatitis, TB and STIs in Europe “Integrate.” Presented at: 49th Union World Conference on Lung Health; 2018 24-27 October; The Haag, the Netherlands.
Raben D on behalf of HIV in Europe and Integrate Joint Action. Integrate. Presented at: Diagnostics meeting with community service providers and developers; 2018 7-9 September; Berlin, Germany.
Casabona J for Integrate Joint Action. Integrate. Presentation presented at: Screening and prevention for viral Hepatitis and HIV in CEE: Common challenges joint solutions; 2018 28-29 July; Sofia, Bulgaria.
D Simões for HIV in Europe. Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia. Presentation presented at: The 22nd International AIDS Conference; 2018 23-27 July; Amsterdam, the Netherlands.
Raben D on behalf of HIV in Europe. Implementing the SDG agenda to leave no one behind: Innovations in Europe on the Fast Track to ending AIDS. Presentation presented at: The 22nd International AIDS Conference; 2018 23-27 July; Amsterdam, the Netherlands.
Power L for OptTEST by HiE. How legal and regulatory barriers to HIV healthcare currently operate (for migrants) in European countries. Presented at: EATG- European Africa Foundation M-CARE training; 2018 5-8 June; Warsaw, Poland.
Power L for OptTEST by HiE. Modernising HIV testing across Europe, How and why legal and regulatory barriers hinder modern and efficient HIV testing across Europe. Presented at: EATG STEP-UP training. 2018 7-10 June; Kiev, Ukraine
Combs L on behalf of European Testing Week. European Testing Week. Presented at: COBATEST Annual Network Meeting. 2018 18 May; Barcelona, Spain.
Raben D for HIV in Europe and Integrate Joint Action. INTEGRATE Joint Action on overcoming barriers to services integration to improve quality of care. Presented at: EU Think Tank on HIV, TB and Hep; 2018 16-17 May; Luxembourg, Luxembourg.
Von Lingen AI for the European Testing Week Working Group. European Testing Week. Presented at: EU Civil Society Forum on HIV, TB and Hep; 2018 14-15 May, Luxembourg, Luxembourg.
Raben D on behalf of European Testing Week. European Hepatitis-HIV Testing Week. Presentation presented at: ECDC/WHO Joint Meeting on HIV in Europe and central Asia in the era of the SDGs: operationalizing goals and achieving targets; 2018 23-25 April; Berlin, Germany.
HepHIV 2017 Malta. OptTEST at Oral presentations:
- Test and link to care: How do we measure our success? By Valerie Delpech (PHE)
- Indicator Condition-Guided HIV testing – progress and challenges. By Ann Sullivan (SSAT)
- Cost-effectiveness of HIV testing: frequency and target groups. By Yazdan Yazdanpanah (INSERM)
- Factors for Delayed Linkage to Care Following HIV Diagnosis in the WHO European Region. By Sara Croxford (PHE) et al.
- Monitoring HIV Indicator Condition-Based HIV Testing in Estonia. By Kristi Rüütel & Liis Lemsalu (NIHD)
- Barring the Way to Health: How Legal and Regulatory Barriers Hinder Modernising HIV Testing across Europe. By Lisa Power et al.
- Monitoring anonymous HIV testing in Estonia in 2005–2015. By Rüütel, K., Kallavus, K., Tomera I (NIHD)
- Review of Specialty Guidelines on HIV Testing Recommendations for HIV Indicator Conditions in Spain. By Vicky Hernando et al. (ISCIII)
- HIV Testing Improvement in Primary Care through OptTEST’s Indicator Condition-Guided Testing: The Tool-1 and Plan-Do-Study-Act Experience in Catalonia, 2017. Rossie Lugo et al.
- Monitoring of HIV Testing Guidance Implementation in Estonia. 2017. By Kristi Ruutel & Liis Lemsalu (NIHD)
J del Amo. Coste-efectividad de la realización de la prueba de VIH en atención primaria en España, Invited talk in the meeting of SEISIDA (Spanish Multidisciplinary society on HIV/AIDS); 22-24 March 2017, Sevilla: XVIII National Congress on AIDS and STIs.
Joint Euro HIV Edat-OptTEST Final Conference & Launch of INTEGRATE Joint Action, 19 September 2017, Brussels, Belgium. OptTEST presentations:
- Raben D. The OptTEST Project - overall conclusions/outcomes.
- Lord E. How to enhance provider initiated testing.
- Bilidas R. Advocacy tool kits overcoming Sigma and regulatory barriers.
- Hows J. Demonstration projects overcoming Sigma and regulatory barriers.
- Sullivan A. IC-guided testing interventions.
- Croxford S. Linkage to care in Europe.
- Amo J del. Modelling data on cost-effectiveness of HIV testing strategies.
- Ruutel K. Cost-effectiveness Estonia.
- Sullivan A. Monitoring and testing in health care settings.
- Raben D. INTEGRATE overview.
- Delpech V. Regional workshops.
ESCAIDE, 28-30 November 2016, Stockholm, Sweden:
Oral presentation: Evaluating impact, added value, relevance and usability of ECDC’s 2010 HIV testing guidance
HIV Drug Therapy, 24-26 October 2016, Glasgow, Scotland:
Poster presentation: Integrated HIV, Hepatitis B and Hepatitis C Testing during the 2015 European Testing Week
2016 HIV DIagnostics Conference, 21-24 March 2016, Atlanta, Georgia, USA
Poster Presentation: Increase in HIV Testing during European Testing Week and Type of Tests Used
Sullivan A, et al (2016): HIV testing in Europe: Evaluating impact, added value, relevance and usability of ECDC’s 2010 HIV testing guidance.
Sperle I, on behalf of the Testing Week Working group. (2016) Increase in HIV testing during European testing week and type of tests used.
Power L, et al. (2016): Ways in which Legal and regulatory barriers hinder the HIV care continuum and the 90/90/90 goals across Europe [Poster presentations], HIV Drug Therapy, Glasgow, October 2016.
Lemsalu L, et al. (2016): Changes in quality of life of PLHIV in Estonia from 2003 to 2015 [Poster presentation], IAS, Durban July 2016.
Power L (2016): Testing in Europe. What's hindering and what's helping? [Presentation], EATG/AVAC 2nd HIV Prevention Summit, Brussels, January 2016.
15th European AIDS Conference, 21-24 October 2015, Barcelona, Spain
Poster Presentation: PE21/28 Ongoing Mononucleosis-like Illness – A Clear Indicator Condition for HIV Testing: Results from the HIDES 2 Study – Single Arm Extension
2015 NATIONAL SUMMIT ON HCV AND HIV DIAGNOSIS, PREVENTION AND ACCESS TO CARE
Poster Presentation: Expansion of HIV Testing The 2014 European HIV testing week
Oral presentation: Expansion of HIV Testing The 2014 European HIV testing week
I Sperle on behalf of the Testing Week Working group. Expansion of HIV Testing. The 2014 European HIV testing week. At 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care, 4-6 June 2015, Virginia, US.
Results of the evaluation of the 2014 European HIV Testing week, presentation at HIV/AIDS Think Tank, 7-8 July 2015, Luxembourg.
14th European AIDS Conference, 16-20th October 2013, Brussels, Belgium
Presentation: Auditing HIV Testing across Europe: results from HIDES2
Friday, 18 October 2013
EACS Presentation October 18, 2013
The 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention, and Access to Care November 26-28, 2012, Washington, DC
Reducing barriers to HIV testing – what influences testing offer and uptake? Lessons learned from the HIV in Europe Initiative, D Raben
The XIX International AIDS Conference, July 22-27, 2012, Washington DC USA
Regional Session on Europe, 24 July, 16:30-18, session room 5
The HIV in European Region, Unity and Diversity, Tallinn, May 2011
A pilot feasibility study of HIV testing in selected indicator conditions,Ann Sullivan on behalf of the HIV Indicator Diseases across Europe study group and the HIV in Europe initiative
AIDS 2011, PLHIV Stigma Index Workshop:
Late testing late treatment
Overview of the PLHIV Stigma Index
Global results overview PLHIV Stigma Index
Estonia Poland Moldova Turkey Ukraine Results
Estonia results presentation
Turkey results presentation
Poland results presention
Estonia PLHIV Stigma Index
Moldova results presentation - Russian
Moldova results word document - Russian
Ukraine results presentation - Russian
Ukraine PLHIV Stigma Index - Russian
The International AIDS Conference in Vienna, 18 - 23 July 2010
Oral presentation: Ensuring optimal HIV treatment in Europe: Overcoming obstacles to late presentation
Dr Jeffrey V. Lazarus, on behalf of the HIV in Europe Initiative
Poster presentation: Overcoming obstacles to late presentation for HIV in Europe
Presentation of the HiE initiative and project results.
The implementation of the stigma index is supported by HIV in Europe in 5 countries.
Poland stigma index presentation at the Vienna conference.
2010 National Summit on HIV Diagnosis, Prevention, and Access to Care, Washington, November
2010, Poster presentation by Nikos Dedes
10th International Congress on Drug Therapy in HIV Infection, Glasgow. November 2010, A pilot
study to determine the prevalence of HIV in persons presenting for care with selected conditions:
preliminary results from the HIV in Europe study, Anders Sönnerborg on behalf of the HIV
Indicator Diseases Across Europe Study Group
EU HIV/AIDS Think Tank, Update on the HIV in Europe Initiative, Ton Coenen, October 2010
EU HIV/AIDS Civil Society Forum, Update on the HIV in Europe Initiative, Ton Coenen, October
12th European AIDS Conference, Cologne, November 2009, The "HIV in Europe" Initiative: Progress
Towards Testing and Earlier Care, Lunch Session
EACS Cologne, November 2009
The "HIV in Europe" Initiative: Progress Towards Testing and Earlier Care
See presentations from the session